FIGURE 5.

Creatinine levels after initiating and discontinuation of tepotinib in Japanese patients. (A) Box plots* for creatinine values over time; (B) Line graph showing creatinine values before and after tepotinib in patients with post‐treatment data available; (C) Line graph showing creatinine value before and after tepotinib in patients who had treatment interruptions^† due to blood creatinine increase. *Time points with data from 10 or fewer patients are not presented, with the exception of baseline, end of treatment and 30‐day safety follow‐up visits. ^†In (C), the positioning of numbers along the dashed line reflects the timings of treatment interruptions, with values corresponding to the number of interruption days at each instance. 1L, first line; 2L+, second‐or‐later line, EoT, end of treatment; FU, 30‐day safety follow‐up.